Thrombin-like serine protease, antiquorin from Euphorbia antiquorum latex induces platelet aggregation via PAR1-Akt/p38 signaling axis

https://doi.org/10.1016/j.bbamcr.2020.118925Get rights and content
Under an Elsevier user license
open archive

Highlights

  • Antiquorin, a thrombin-like serine protease isolated from Euphorbia antiquorum latex

  • Antiquorin activates intrinsic and common pathways of blood coagulation.

  • Antiquorin alleviates bleeding and accelerates wound healing in mice.

  • Antiquorin induces intracellular signaling and platelet aggregation via PAR-1.

Abstract

Plant latex proteases (PLPs) are pharmacologically essential and are integral components of traditional medicine in the management of bleeding wounds. PLPs are known to promote blood coagulation and stop bleeding by interfering at various stages of hemostasis. There are a handful of scientific reports on thrombin-like enzymes characterized from plant latices. However, the role of plant latex thrombin-like enzymes in platelet aggregation is not well known. In the present study, we attempted to purify and characterize thrombin-like protease responsible for platelet aggregation. Among tested plant latices, Euphorbia genus latex protease fractions (LPFs) induced platelet aggregation. In Euphorbia genus, E. antiquorum LPF (EaLPF) strongly induced platelet aggregation and attenuated bleeding in mice. The purified thrombin-like serine protease, antiquorin (Aqn) is a glycoprotein with platelet aggregating activities that interfere in intrinsic and common pathways of blood coagulation cascade and alleviates bleeding and enhanced excision wound healing in mice. In continuation, the pharmacological inhibitor of PAR1 inhibited Aqn-induced phosphorylation of cPLA2, Akt, and P38 in human platelets. Moreover, Aqn-induced platelet aggregation was inhibited by pharmacological inhibitors of PAR1, PI3K, and P38. These data indicate that PAR1-Akt/P38 signaling pathways are involved in Aqn-induced platelet aggregation. The findings of the present study may open up a new avenue for exploiting Aqn in the treatment of bleeding wounds.

Abbreviations

PLPs
plant latex proteases
LPFs
latex protease fractions
EaLPF
E. antiquorum LPF
EaPRF
E. antiquorum protease rich fraction
Aqn
antiquorin

Keywords

Blood coagulation
Bleeding time
Bypassing agent
cPLA2
Factor VIII
NF-κB

Cited by (0)

1

Present address: The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

2

These authors contributed equally.